8:30 AM

Missing Data and Sensitivity Analyses presented by Abel Eshete, FDA

9:30 AM

Statistical Considerations for Surrogate Endpoint Evaluation presented by Feng Li, FDA

11:00 AM

Panel Discussion: The Impact of Artificial Intelligence in Biopharmaceutical Statistics

Panelists:

Vipin Arora, Pacira Biosciences –

CV Damaraju, Johnson and Johnson –

Melvin Munsaka, AbbVie –

Robert Perera, Virginia Commonwealth University

9:00 AM

Advancing Precision Medicine: From Targeted Therapy Development to Individualized Treatment Recommendation presented by Dr. Na Bo, Virginia Commonwealth University

10:30 AM

Open Drug Discovery at the Speed of AI presented by Dr. Jake Chen, The University of Alabama at Birmingham School of Medicine

12:30 PM

Title To Be Announced presented by Mr. Zack Wintrob, Emmes